Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-N-acetyllactosamine.
Two hybridoma antibodies (VEP8 and VEP9) raised against the promyelomonocytic leukemia cell line HL60 have previously been shown to distinguish human granulocytes and monocytes from other cells of the peripheral blood. We report here that both antibodies recognize the carbohydrate structure 3-fucosyl-N-acetyllactosamine with the following sequence: (formula; see text) This structure is the same as that recognized by a hybridoma antibody against mouse teratocarcinoma cells (anti-SSEA-1) which recognizes an early embryonic antigen in the mouse. Until recently this carbohydrate structure was considered to be rare among glycoproteins and glycosphingolipids. However, there is a growing list of human and animal glycoproteins in which this sequence has been detected by chemical and immunochemical methods. In this article we survey this information and discuss how this and other carbohydrate structures behave as differentiation- or tumor-associated antigens.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D002460:Cell Line; D000939:Epitopes / Q000276:immunology; D006098:Granulocytes / Q000276:immunology*; D006801:Humans; D016256:Lewis X Antigen / Q000276:immunology*; D051379:Mice; D009000:Monocytes / Q000276:immunology*; D009844:Oligosaccharides / Q000276:immunology*; D009961:Orosomucoid / Q000032:analysis; D013724:Teratoma / Q000276:immunology
D000911:Antibodies, Monoclonal; D000939:Epitopes; D016256:Lewis X Antigen; D009844:Oligosaccharides; D009961:Orosomucoid